Prenatal dopamine and neonatal behavior and biochemistry.
Depressed pregnant women (N=126) were divided into high and low prenatal maternal dopamine (HVA) groups based on a tertile split on their dopamine levels at 20 weeks gestation. The high versus the low dopamine group had lower Center for Epidemiological Studies-Depression Scale (CES-D) scores, higher norepinephrine levels at the 20-week gestational age visit and higher dopamine and serotonin levels at both the 20- and the 32-week gestational age visits. The neonates of the mothers with high versus low prenatal dopamine levels also had higher dopamine and serotonin levels as well as lower cortisol levels. Finally, the neonates in the high dopamine group had better autonomic stability and excitability scores on the Brazelton Neonatal Behavior Assessment Scale. Thus, prenatal maternal dopamine levels appear to be negatively related to prenatal depression scores and positively related to neonatal dopamine and behavioral regulation, although these effects are confounded by elevated serotonin levels.
Field
Tiffany
T
Touch Research Institutes, University of Miami Medical School, Miami, FL 33101, USA. tfield@med.miami.edu
Diego
Miguel
M
Hernandez-Reif
Maria
M
Figueiredo
Barbara
B
Deeds
Osvelia
O
Ascencio
Angela
A
Schanberg
Saul
S
Kuhn
Cynthia
C
D000328:Adult; D003866:Depressive Disorder / Q000175:diagnosis / Q000523:psychology / Q000652:urine; D004298:Dopamine; D005260:Female; D006801:Humans; D018730:Infant Behavior / Q000502:physiology* / Q000523:psychology*; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000523:psychology* / Q000652:urine*; D011295:Prenatal Care / Q000379:methods; D011297:Prenatal Exposure Delayed Effects / Q000523:psychology* / Q000652:urine*; D055815:Young Adult
D004298:Dopamine
J Child Psychol Psychiatry. 2001 Sep;42(6):777-83
11583250
Acta Psychiatr Scand Suppl. 2005;(427):14-21
15877719
Am J Psychiatry. 1980 Sep;137(9):1081-4
7425160
Psychoneuroendocrinology. 2006 Aug;31(7):876-88
16769179
J Clin Psychiatry. 2006;67 Suppl 6:3-8
16848670
Psychiatry. 2004 Spring;67(1):63-80
15139586
Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):531-4
16414168
Hum Psychopharmacol. 2006 Mar;21(2):91-9
16444772
Curr Drug Targets. 2006 Feb;7(2):177-85
16475959
Mol Psychiatry. 1998 May;3(3):238-46
9672899
Monogr Soc Res Child Dev. 1978;43(5-6):1-13
752799
Metabolism. 2005 May;54(5 Suppl 1):24-7
15877309
J Child Psychol Psychiatry. 2006 Nov;47(11):1143-51
17076753
J Clin Psychiatry. 2006;67 Suppl 6:27-32
16848674
J Neurosci Methods. 1984 Sep;11(4):257-73
6513585
Fundam Clin Pharmacol. 2004 Dec;18(6):601-7
15548230